The Covid-19 epidemic highlighted the disproportionate way the virus impacted minority communities across the U.S., increasing the calls for racial and ethnic diversity in clinical studies. While there has been a more significant push, a recent Pfizer clinical trials diversity report shows there is still a wide gap that needs to be bridged.

Covid-19 was the primary or contributing cause of 377,883 deaths in the United States during 2021, with a particularly high toll among the elderly, according to a government report released on March 31.

Mayor Bill de Blasio’s chief medical adviser on Feb. 25 downplayed the results of two studies suggesting that a new coronavirus variant found in New York City in November will be more resistant to vaccines now being administered.

closerlook inc. is alerting Black creatives about a free, 16-week portfolio program established by nonprofit One Club for Creativity known as ONE School.

Drug developer Novavax Inc. completed enrolling 30,000 volunteers in a late-stage study of the company’s Covid-19 vaccine in the United States and Mexico.

Feb. 5 was a different sort of Opening Day at Yankee Stadium, the legendary home of baseball’s “Bronx Bombers,” as New York ramped up its drive to vaccinate the state’s most vulnerable residents, many who live in the hard-hit Bronx neighborhoods that surround the legendary sports venue.

In honor of World Cancer Day, FCB Health Network announced “The Trial for #ClinicalEquality,” an initiative dedicated to achieving racial equity in clinical trials.

Many Americans are hesitant to be vaccinated against Covid-19, according to research from Invisibly.

The microscopic organisms living in our intestines may influence the severity of Covid-19 and the body’s immune response to it, and could account for lingering symptoms, researchers reported.

Leadership teams from the 2020 Manny Award winners and finalists participated in a Q&A forum to offer their analysis on a variety of healthcare industry themes and trends.